<DOC>
	<DOCNO>NCT02930941</DOCNO>
	<brief_summary>It estimate epistaxis result 4.5 million emergency department visit per year throughout United States . Due adverse effect standard treatment option epistaxis , tranexamic acid ( TXA ) may consider attractive option . In previous study , use nasal packing , TXA show fast time control bleed . The goal study determine efficacy safety topical intranasal TXA apply via atomizer patient epistaxis present emergency department .</brief_summary>
	<brief_title>Topical Intranasal Tranexamic Acid Epistaxis Emergency Department</brief_title>
	<detailed_description>This prospective , randomize , single-center , double-blinded , placebo control study compare efficacy safety topical intranasal tranexamic acid epistaxis . The primary outcome time control bleed secondary outcome length stay emergency department , re-bleeding within first 24 hour , re-bleeding one week . Safety outcomes incidence thromboembolic event drug-related adverse event . Patients age 18 year age old diagnose anterior epistaxis include . Patients exclude unable consent , valid telephone number , pregnant woman , prisoner , cognitively impaired individual , diagnosis posterior epistaxis , major trauma , bleed disorder ( thrombocytopenia hemophilia ) , hemodynamically unstable , know hypersensitivity study medication . Patients randomly assign tranexamic acid treatment group placebo group . After consent , patient receive TXA ( 100 mg/1mL ) 0.9 % sodium chloride ( 1 mL ) affect nostril ( ) via intranasal atomization device . If bleeding cease , two repeat dos allow twenty minute continue bleed study physician could treat additional treatment option . Patients contact via telephone within one week inquire incidences re-bleeding complication .</detailed_description>
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Epistaxis</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Diagnosed anterior epistaxis Unable consent , valid telephone number , pregnant woman , prisoner , cognitively impaired individual , diagnosis posterior epistaxis , major trauma , bleed disorder ( thrombocytopenia hemophilia ) , hemodynamically unstable , know hypersensitivity study medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>tranexamic acid</keyword>
	<keyword>epistaxis</keyword>
	<keyword>emergency medicine</keyword>
	<keyword>intranasal</keyword>
	<keyword>TXA</keyword>
</DOC>